NEW YORK, May 5, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Stemline Therapeutics, Inc. ("STML" or the "Company") (NASDAQ: STML) in connection with the proposed acquisition of the Company...
from PR Newswire: https://ift.tt/2zh6kyE
No comments:
Post a Comment